0001209191-16-157109.txt : 20161230
0001209191-16-157109.hdr.sgml : 20161230
20161230172229
ACCESSION NUMBER: 0001209191-16-157109
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140219
FILED AS OF DATE: 20161230
DATE AS OF CHANGE: 20161230
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Conatus Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001383701
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203183915
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16745 WEST BERNARDO DRIVE
STREET 2: Suite 200
CITY: San Diego
STATE: CA
ZIP: 92127
BUSINESS PHONE: (858) 376-2600
MAIL ADDRESS:
STREET 1: 16745 WEST BERNARDO DRIVE
STREET 2: Suite 200
CITY: San Diego
STATE: CA
ZIP: 92127
FORMER COMPANY:
FORMER CONFORMED NAME: Conatus Pharmaceuticals Inc
DATE OF NAME CHANGE: 20061214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KISNER DANIEL L
CENTRAL INDEX KEY: 0001073407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36003
FILM NUMBER: 162078050
MAIL ADDRESS:
STREET 1: 2292 FARADAY AVENUE
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2014-02-19
2014-02-25
0
0001383701
Conatus Pharmaceuticals Inc.
CNAT
0001073407
KISNER DANIEL L
C/O CONATUS PHARMACEUTICALS INC.
16745 WEST BERNARDO DRIVE, SUITE 200
SAN DIEGO
CA
92127
1
0
0
0
Common Stock
2014-02-19
4
J
0
3145
0.00
A
3145
I
See footnote
Represents a pro rata distribution of 2,137 shares from Aberdare Partners III, L.P., of which the Reporting Person is a limited partner, and a pro rata distribution of 1,008 shares from Aberdare GP III, L.L.C., of which the Reporting Person is a non-managing member.
Held by family trust of which the Reporting Person is a trustee.
This Form 4/A amends the Form 4 filing made on behalf of the Reporting Person on February 25, 2014. The Form 4, as originally filed, incorrectly reported the ownership form as direct in Table I, Column 6.
The amount of securities beneficially owned in Table I, Column 5 in the Form 4 filing made on behalf of the Reporting Person on April 10, 2015 incorrectly included the 3,145 shares of common stock acquired on February 19, 2014 as held in direct ownership form.
/s/ Charles J. Cashion, as Attorney-in-Fact for Daniel L. Kisner
2016-12-30